Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-04-09 | New | $3,600,000 | $3,600,000 | Debt Only | 06b | SEC link |
2025-02-12 | New | $600,000 | $600,000 | Debt Only | 06b | SEC link |
2023-12-01 | New | $6,999,988 | $6,999,988 | Equity Only | 06b | SEC link |
2022-09-29 | New | $5,000,000 | $5,000,000 | Debt Only | 06b | SEC link |
2021-02-18 | New | $4,199,985 | $4,199,985 | Equity Only | 06b | SEC link |
2020-08-17 | Amended | $5,706,889 | $699,989 | Equity Only | 06b | SEC link |
2019-12-02 | New | $5,006,900 | $5,006,900 | Equity Only | 06b | SEC link |
2018-06-25 | New | $3,999,998 | $3,999,998 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Shauna Callahan | Director |
Jeffrey Cleland | Director |
Maiko Katadae | Director |
Akihiro Ko | Director, Executive |
Minoru Ko | Director |
Hiroaki Kobayashi | Director |
Naonori Kurokawa | Director |
Thomas White | Director |